Régis Perbost

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

Nathalie Scholler, Régis Perbost, Frederick L. Locke et al. · Nature Medicine · 2022 · 198 citations · Full text

Medicine, Immunology, Oncology +17

Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma

Frederick L. Locke, Simone Filosto, Justin Chou et al. · Nature Medicine · 2024 · 108 citations · Full text

Medicine, Immunology, Oncology +11

Association of pretreatment (preTx) tumor characteristics and clinical outcomes following second-line (2L) axicabtagene ciloleucel (axi-cel) versus standard of care (SOC) in patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL).

Frederick L. Locke, Justin Chou, Saran Vardhanabhuti et al. · Journal of Clinical Oncology · 2022 · 10 citations

Medicine, Oncology, Cancer Immunology +13